Proteins are commonly used as molecular targets against pathogens such as viruses and bacteria. However, pathogens can evolve rapidly permitting their populations to increase in protein diversity over time and thus escape to the activity of a molecular therapy. Subsequently, in order to design more durable and robust therapies as well as to understand viral evolution in a host and subsequent transmission, it is central to understand the evolution of pathogen proteins. This understanding can enable the detection of protein regions that can be potential targets for therapies and predict the emergence of molecular resistance against therapies. In this direction, two articles published recently in the Journal of Molecular Evolution investigated the evolution of proteomes of diverse flaviviruses, including Zika virus, Dengue virus and West Nile virus. Here I discuss the importance of considering the evolution of viral proteins, with the use of as realistic as possible models and methods that mimic protein evolution, to improve the design of antiviral therapies.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Abadi S, Azouri D, Pupko T, Mayrose I (2019) Model selection may not be a mandatory step for phylogeny reconstruction. Nat Commun 10:934
Abascal F, Posada D, Zardoya R (2007) MtArt: a new model of amino acid replacement for Arthropoda. Mol Biol Evol 24:1–5
Arbiza L, Patricio M, Dopazo H, Posada D (2011) Genome-wide heterogeneity of nucleotide substitution model fit. Genome Biol Evol 3:896–908
Arenas M (2015) Trends in substitution models of molecular evolution. Front Genet 6:319
Arenas M, Bastolla U (2020) ProtASR2: ancestral reconstruction of protein sequences accounting for folding stability. Methods Ecol Evol 11:248–257
Arenas M, Posada D (2010) Computational design of centralized HIV-1 genes. Curr HIV Res 8:613–621
Arenas M, Araujo NM, Branco C, Castelhano N, Castro-Nallar E, Perez-Losada M (2018) Mutation and recombination in pathogen evolution: relevance, methods and controversies. Infect Genet Evol 63:295–306
Bastolla U, Arenas M (2019) The influence of protein stability on sequence evolution: applications to phylogenetic inference. In: Sikosek T (ed) Computational methods in protein evolution. Springer, New York, pp 215–231
Bordner AJ, Mittelmann HD (2013) A new formulation of protein evolutionary models that account for structural constraints. Mol Biol Evol 31:736–749
Chong B, Li M, Li T, Yu M, Zhang Y, Liu Z (2018) Conservation of potentially druggable cavities in intrinsically disordered proteins. ACS Omega 3:15643–15652
Dang CC, Le QS, Gascuel O, Le VS (2010) FLU, an amino acid substitution model for influenza proteins. BMC Evol Biol 10:99
de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, Zhu X, Kaplan JB, Pitts JD et al (2018) Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein. Cell Chem Biol 25(1006–1016):e1008
Del Amparo R, Vicens A, Arenas M (2020) The influence of heterogeneous codon frequencies along sequences on the estimation of molecular adaptation. Bioinformatics 36:430–436
Echave J, Wilke CO (2017) Biophysical models of protein evolution: understanding the patterns of evolutionary sequence divergence. Annu Rev Biophys 46:85–103
Echave J, Spielman SJ, Wilke CO (2016) Causes of evolutionary rate variation among protein sites. Nat Rev Genet 17:109–121
Gerth M (2019) Neglecting model selection alters phylogenetic inference. bioRxiv. https://doi.org/10.1101/849018v1.abstract
Gould EA, Solomon T (2008) Pathogenic flaviviruses. Lancet 371:500–509
Gubler DJ (2002) The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33:330–342
Ishikawa T, Yamanaka A, Konishi E (2014) A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine 32:1326–1337
Jiménez-Santos MJ, Arenas M, Bastolla U (2018) Influence of mutation bias and hydrophobicity on the substitution rates and sequence entropies of protein evolution. PeerJ 6:e5549
Kaehler BD, Yap VB, Huttley GA (2017) Standard codon substitution models overestimate purifying selection for nonstationary data. Genome Biol Evol 9:134–149
Keane TM, Creevey CJ, Pentony MM, Naughton TJ, McLnerney JO (2006) Assessment of methods for amino acid matrix selection and their use on empirical data shows that ad hoc assumptions for choice of matrix are not justified. BMC Evol Biol 6:29
Le TK, Vinh LS (2020) FLAVI: an amino acid substitution model for flaviviruses. J Mol Evol. In press
Lemey P, Rambaut A, Pybus OG (2006) HIV evolutionary dynamics within and among hosts. AIDS Rev 8:125–140
Lemmon AR, Moriarty EC (2004) The importance of proper model assumption in bayesian phylogenetics. Syst Biol 53:265–277
Liberles DA, Teufel AI, Liu L, Stadler T (2013) On the need for mechanistic models in computational genomics and metagenomics. Genome Biol Evol 5:2008–2018
Luo D, Vasudevan SG, Lescar J (2015) The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Antiviral Res 118:148–158
Nickle DC, Heath L, Jensen MA, Gilbert PB, Mullins JI, Kosakovsky Pond SL (2007) HIV-specific probabilistic models of protein evolution. PLoS ONE 2:e503
Nunez-Castilla J, Rahaman J, Ahrens JB, Balbin CA, Siltberg-Liberles J (2020) Exploring evolutionary constraints in the proteomes of Zika, Dengue and other flaviviruses to find fitness-critical sites. J Mol Evol 88:399–414
Ortiz JF, MacDonald ML, Masterson P, Uversky VN, Siltberg-Liberles J (2013) Rapid evolutionary dynamics of structural disorder as a potential driving force for biological divergence in flaviviruses. Genome Biol Evol 5:504–513
Ribeiro AJM, Tyzack JD, Borkakoti N, Holliday GL, Thornton JM (2020) A global analysis of function and conservation of catalytic residues in enzymes. J Biol Chem 295:314–324
Spielman SJ, Kosakovsky Pond SL (2018) Relative evolutionary rates in proteins are largely insensitive to the substitution model. Mol Biol Evol 35:2307–2317
Voskarides K (2020) Animal-to-human viral transitions: is SARS-CoV-2 an evolutionary successful one? J Mol Evol. In press
Wang S, Liu Y, Guo J, Wang P, Zhang L, Xiao G, Wang W (2017) Screening of FDA-approved drugs for inhibitors of Japanese encephalitis virus infection. J Virol 91:e01055-17
Wilke CO (2012) Bringing molecules back into molecular evolution. PLoS Comput Biol 8:e1002572
Woodford N, Ellington MJ (2007) The emergence of antibiotic resistance by mutation. Clin Microbiol Infect 13:5–18
Xue B, Dunker AK, Uversky VN (2012) Orderly order in protein intrinsic disorder distribution: disorder in 3500 proteomes from viruses and the three domains of life. J Biomol Struct Dyn 30:137–149
I thank the Grants “RYC-2015-18241” (MA) from the Spanish Ministry of Economy and Competitivity and “ED431F 2018/08” (MA) from the Xunta de Galicia that support my research.
Conflicts of interest
The author declares no conflict of interest.
Handling editor: David Liberles.
About this article
Cite this article
Arenas, M. Protein Evolution in the Flaviviruses. J Mol Evol 88, 473–476 (2020). https://doi.org/10.1007/s00239-020-09953-1
- Protein evolution
- Virus evolution
- Molecular adaptation
- Substitution process
- Antiviral therapy